Introduction
A heterodimeric transcription factor PEBP2 was initially identi®ed as a polyomavirus enhancer binding protein induced in embryonal carcinoma F9 cells after they undergo dierentiation upon retinoic acid treatment (reviewed by Ito, 1996) . It is composed of a and b subunits (Kamachi et al., 1990) . The a subunit encoding-gene is the mammalian homolog of the Drosophila genes, runt and lozenge. runt is one of the segmentation genes belonging to the primary pair-rule class and also involved in sex determination and neuronal development (Kania et al., 1990) . lozenge, on the other hand, de®nes the fate of certain cells arisen from the second wave of mitotic division in Drosophila eye development (Daga et al., 1996) . There are three mammalian genes which encode the a subunit. They are PEBP2aA (Ogawa et al., 1993b) , AML1/PEBP2aB (Bae et al., 1993 (Bae et al., , 1994 and PEBP2aC (Bae et al., 1995; Levanon et al., 1994; Wijimenga et al., 1995) . The a subunit contains the evolutionarily conserved 128 amino acid region termed the Runt domain responsible for the DNA binding and the heterodimerization activities . PEBP2 is identical to core binding factor (CBF) which was identi®ed as a factor interacting with the core motif of murine leukemiavirus enhancer (Wang et al., 1993) . The three mammalian genes encoding the a subunit are, therefore, also called Cbfa1, Cbfa2 and Cbfa3, respectively (Wijimenga et al., 1995) . Only one gene is known to encode the mammalian b subunit, termed PEBP2b/Cbfb (Ogawa et al., 1993a; Wang et al., 1993) , whereas two genes, brother and big brother, are known in Drosophila (Golling et al., 1996) .
The AML1 gene identi®ed at the breakpoint of chromosome translocation t(8;21) associated with human acute myeloid leukemia (Miyoshi et al., 1991) was subsequently found to encode the a subunit of PEBP2/CBF (Bae et al., 1993) . It is now known that AML1/PEBP2aB/Cbfa2 is the most frequent target of chromosome translocations so far observed in human leukemia in myeloid and lymphoid lineages. By targeted mutagenesis studies, AML1/PEBP2aB/Cbfa2 has been shown to be essential for the de®nitive hematopoiesis (Okada et al., unpublished data; Okuda et al., 1996; Wang et al., 1996b) . The gene disruption studies also revealed that the phenotype of the AML1/ PEBP2aB/Cbfa2 knock-out and the PEBP2b/Cbfb knock-out mice are identical (Niki et al., 1997, in press; Sasaki et al., 1996; Wang et al., 1996a) . The results clearly show that each subunit alone cannot exert the PEBP2 function and that the two subunits must function together in vivo.
The b subunit associates well with all three a subunits (Ogawa et al., 1993b; Bae et al., 1994 Bae et al., , 1995 . This means that structural alterations of any one of the a or b subunit genes would have potential to aect the regulatory role of others. In the case of acute myeloid leukemia with inv(16) involving the structural alteration of the b subunit (Liu et al., 1993) , expression of target genes regulated by all three a subunit genes would clearly be aected. To understand the leukemogenic processes thoroughly, it is essential to study the function of all three a subunit genes.
PEBP2aA has been shown to be expressed in mouse thymus throughout its developmental stages, although the level of expression is lower than that of AML1/ PEBP2aB/Cbfa2 . The gene has been mapped to the central region of mouse chromosome 17. This locus is homologous to human chromosome 6p, 19p or 5q (Bae et al., 1994) . This paper describes the cDNA sequence of human PEBP2aA. Isolation of the human cDNA allowed us to map the human PEBP2aA locus to chromosome 6p12.3-p21.1. The targeted mutagenesis of the mouse PEBP2aA/Cbfa1 gene revealed that PEBP2aA/Cbfa1 is essential for maturation of osteoblasts and is a key regulator of bone speci®c gene expression (Komori et al., in press ). The map position of the human PEBP2aA suggests a strong link of the gene to a human bone disease, cleidocranial dysplasia (Jarvis and Keats, 1974) , previously mapped to 6p21 (Mundlos et al., 1995) .
Results and discussion
Cloning of human PEBP2aA cDNA
In order to isolate human cDNAs encoding the Runt domain of PEBP2, we screened the cDNA library prepared from a human T-cell line using, as a probe, the mouse cDNA fragment containing the Runt domain region of PEBP2aA1 (Ogawa et al., 1993b) . From this screening, the cDNA clones representing human PEBP2aA, PEBP2aB/AML1 and PEBP2aC were isolated. Of them, those representing PEBP2aB/ AML1 and PEBP2aC were described (Ahn et al., 1996; Bae et al., 1995) . Here we describe the cDNAs of human PEBP2aA gene.
Two types of human PEBP2aA cDNAs were isolated. One represented the human counterpart of the mouse major splice form, termed PEBP2aA1, characterized by the highly conserved ®ve amino acid sequence, VWRPY, at the extreme carboxy-terminus of the protein product (Ogawa et al., 1993b) . The VWRPY motif is present not only in the major products of all three mammalian Runt domain genes but also in the products of Drosophila runt and lozenge as well as that of C. elegans runt (reviewed by Ito and Bae, 1997, in press) . Human PEBP2aA1 cDNA is incomplete, lacking the amino-terminal region up to the middle of the Runt domain. This cDNA most likely represents a novel splice variant similar to AML1DN that we described recently (Zhang et al., 1997) . In AML1DN, exon 1 is directly linked to exon 4, generating the cDNA encoding the carboxy-terminal region of AML1 starting at the middle of the Runt domain.
The other represents one of the minor splice variants encoding the protein identical to PEBP2aA1 in its amino-terminal region including the Runt domain but entirely dierent in its carboxy-terminal region downstream of the amino acid corresponding to amino acid 304 of the mouse protein (data not shown). The mouse counterpart of this variant which does not contain the VWRPY motif at the C-terminus was previously isolated and termed PEBP2aA3 (Mitsuo Maruyama and Yoshiaki Ito, unpublished observation). Human PEBP2aA3 cDNA is incomplete, lacking the region encoding the amino-terminal region up to the middle of the glutamine stretch.
A composite sequence of human PEBP2aA1 cDNA is shown in Figure 1 by combining the sequence of the cloned PEBP2aA3 up to the Runt domain and the sequence of the C-terminal to the Runt domain of the cloned PEBP2aA1. The mouse PEBP2aA1 cDNA sequence that we reported earlier (Ogawa et al., 1993b) is also shown for comparison. Human and mouse PEBP2aA1 cDNAs are highly conserved. Overall homology between these two cDNAs is 94%. The homology of the regions encoding the Runt domain is 92%.
In Figure 2 , a diagrammatic representation of human and mouse PEBP2aA1 proteins is shown as compared to the human AML1b/PEBP2aB1 (Miyoshi et al., 1995; Ahn et al., 1996) and human PEBP2aC1 (Miyoshi et al., 1995; Ahn et al., 1996) and human PEBP2aC1 (Bae et al., 1995) . The Runt domain is indicated by hatched box. Q and A indicate the regions of glutamine and alanine stretches, respectively. The gray box indicates the 22 amino acid region of mouse PEBP2aA1 encoded by exon 6. The VWRPY motif is indicated by a black box at the C termini (Bae et al., 1995) . The amino-acid sequences of the Runt domain of human and mouse proteins encoded by the PEBP2aA gene are identical. There are only three amino acids which are dierent but conservative between mouse and human proteins except for the 22 amino acid-sequence lacking in the human protein. The 22 amino acid-sequence is most likely encoded by an independent exon, since the genomic structure of the mouse genome showed that the corresponding region represented exon 6 (Mitsuo Maruyama and Yoshiaki Ito, unpublished result). It is not clear at present whether the major cDNA species in human cells lacks this 22 amino acids or this particular isolate represents a minor species.
Human PEBP2aA1 also contains the glutamine and alanine stretches at its N-terminal region characteristic to PEBP2aA protein (Ogawa et al., 1993b) . The glutamine and alanine stretches are also present in the product of Drosophila lozenge (Daga et al., 1996) . These observations imply potentially important functions inherited to glutamine and alanine stretches in addition to the Runt domain and the VWRPY motif.
Chromosomal localization of human PEBP2aA gene
Using the human PEBP2aA1 cDNA as a probe, the chromosome locus of the gene was determined. We examined 100 typical R-banded (pro)metaphase plates. Of them, 3% exhibited complete twin spots on both homologs, 14% were incomplete single and/or twin spots on either or both homologs, and no spots were detectable in the others (83%). The signals were localized to p12.3-p21.1 band of chromosome 6. No twin spots were observed on other chromosomes. The gene could be, therefore, assigned to the band 6p12.3-p21.1 (Figure 3a and b) .
We showed earlier that the mouse PEBP2aA (pebpa2a, see Bae et al., 1994) locus was mapped to the central region of mouse chromosome 17 which is synthenic to human 6p, 19p or 5q (Bae et al., 1994) . More recently, Levanon et al. reported that human counterpart of PEBP2aA, which they termed AML3, was mapped to human chromosome 6p21. However, neither genomic nor cDNA sequences of human AML3 have been reported to date. When they compared the amino acid sequences of the products of three mammalian Runt domain encoding genes, AML1, AML2 and AML3, they used mouse PEBP2aA1 sequence representing the product of AML3 (Levanon et al., 1994) . It is worth noting that Drosophila has at least two Runt domain encoding genes, runt and lozenge. Surprisingly, the level of homology between the Runt domains encoded by these two genes are only 69% identity. However, the homology among the Runt domains encoded by three mammalian genes is more than 90% identity (reviewed by Ito and Bae, 1997, in press) . It means that mammals may have more Runt domain encoding genes. Therefore, it is not possible to conclude whether AML3 cDNA which Levanon group isolated represents a human homologue of PEBP2aA until the cDNA sequence information of the clone is available. We show here formally that human PEBP2aA maps to 6p12.3-21.1.
It is very interesting to note that human chromosome 6p21 is the locus for autosomal dominant disease, cleidocranial dysplasia (CCD, Mundlos et al., 1995) , characterized by hypoplastic or anaplastic clavicles, open sutures and fontanelles and multiple other skeletal changes (Jarvis and Keats, 1974) . Furthermore, a radiation-induced mouse mutant that shows a phenotype strikingly similar to that of CCD has been described (Mundlos et al., 1996) . The mouse mutant maps to chromosome 17 distal to the MHC complex in an area that shows homology to human 6p (Mundlos et al., 1996) . Previously, we mapped mouse PEBP2aA (pebpa2a) to the central region of chromosome 17, 8.7 centimorgans (cM) distal to H-2 and 9.5 cM proximal to Vav. This locus was synthenic to human 6p, 19p or 5q (Bae et al., 1994) . We now know that human PEBP2aA maps to 6p12.3-p21.1. Recent targeted mutagenesis studies show that homozygous disruption of PEBP2aA/Cbfa1 of the mouse results in complete lack of bone formation. Remarkably, the mouse heterozygous for disrupted PEBP2aA exhibited hypoplastic clavicles and nasal bones and retarded ossi®cation of parietal, interparietal and supraoccipital bones (Komori et al., in press ). Inescapable conclusion would be that PEBP2aA is the most likely candidate for pathogenesis of cleidocranial dysplasia.
Finally, it is worth discussing a possibility that PEBP2 is involved in carcinogenesis in bone cells. In the case of AML1/PEBP2aB and PEBP2b, they could be regarded as protooncogenes, since structural alterations of each of these two genes by chromosome translocation are closely related to leukemogenesis (reviewed by Ito and Bae, 1997, in press) . It is known that expression of bone speci®c genes such as osteocalcin is regulated by PEBP2-like factors (Georoy et al., 1995; Merriman et al., 1995; Banerjee et al., 1996) . Michael Centrella in collaboration with us identi®ed that PEBP2/CBF containing PEBP2aA as an a subunit is responsible for bone cell speci®c expression of the transforming growth factor b (TGF-b) type I receptor gene (in preparation). Likewise, expression of osteopontin gene in bone cells was found to be regulated by PEBP2aA/Cbfa1 (Shintaro Nomura, personal communication). Therefore, a possibility must seriously be considered that the structural changes in PEBP2aA/Cbfa1 are carcinogenic in bone cells. This possibility is currently being investigated. 
Materials and methods

cDNA cloning
A cDNA library was prepared from cytoplasmic polyadenylated RNA of the human adult T-cell line KUT-2 by using the plasmid vector PSI4001 (see Bae et al., 1995) . The library was screened by the colony hybridization method under low-stringency conditions (Sambrook et al., 1989) with a probe containing the 1348 bp SmaI fragment (nucleotides 314 ± 662) derived from mouse PEBP2aA1 cDNA. The probe was labeled with a-32 P-dCTP by using the Rediprime system (Amersham). Washing was performed twice with a solution containing 26SSC (16SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 0.1% sodium dodecyl sulfate (SDS) and then twice with a solution containing 0.56SSC and 0.1% SDS for each 10 min at 428C.
DNA sequencing
The cDNA insert of each positive clone was excised by digestion with EcoRI and MluI and subcloned into the EcoRV site of pBluescript II (KS7) (Stratagene). Deletions of each clone were generated with the exonuclease III/mung bean kit (Stratagene) and used for sequencing. DNA sequencing was performed by the dideoxy-chain termination method (Sequenase kit; US Biochemicals) with double-stranded DNA and T3 or T7 primer.
Nucleotide seqence accession number
The nucleotide sequence of human PEBP2aA1 has been deposited in the GeneBank database. The accession number is L40992.
Chromosomal localization by direct R-banding FISH
For chromosome mapping, the 2.1 kb EcoRI fragment derived from human PEBP2aA1 cDNA was used as a probe. A direct R-banding¯uorescence in situ hybridization (FISH), which is based on FISH combined with replicated prometaphase R-bands, was applied (Takahashi et al., 1990 (Takahashi et al., , 1991a . For the ampli®cation of the signals of this clone, we used the method reported by ViegasPequignot et al. (1989) with slight modi®cations (Takahashi et al., 1991b) . The procedures of labeling, hybridization, rinsing and detection were carried out in a routine manner. Ektachrome ®lm (Kodak, ASA 100) was used for the microphotography (®lter combinations, Nikon B-2A: Exciter 450 ± 490 nm, Barrier 520 nm and B-2E: Exciter 450 ± 490 nm, Barrier 520 nm).
